| MeSH term | MeSH ID | Detail |
|---|---|---|
| Osteoblastoma | D018215 | 1 associated lipids |
| Erythromelalgia | D004916 | 1 associated lipids |
| Fibromuscular Dysplasia | D005352 | 2 associated lipids |
| Atrial Premature Complexes | D018880 | 1 associated lipids |
| Latex Hypersensitivity | D020315 | 1 associated lipids |
| Drowning | D004332 | 2 associated lipids |
| Jejunal Diseases | D007579 | 3 associated lipids |
| Basal Ganglia Hemorrhage | D020145 | 1 associated lipids |
| Radiculopathy | D011843 | 1 associated lipids |
| Intracranial Hemorrhage, Hypertensive | D020299 | 1 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wennmalm A et al. | Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. | 1991 | Circulation | pmid:2022025 |
| Keimowitz RM et al. | Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis. | 1993 | Circulation | pmid:8339418 |
| Frelinger AL et al. | Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization. | 2009 | Circulation | pmid:19996015 |
| Cyrus T et al. | Lipid peroxidation and platelet activation in murine atherosclerosis. | 2001 | Circulation | pmid:11602498 |
| Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
| Kim YD et al. | Effects of CGS-13080, a thromboxane inhibitor, on pulmonary vascular resistance in patients after mitral valve replacement surgery. | 1988 | Circulation | pmid:3409518 |
| Bush LR et al. | Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. | 1984 | Circulation | pmid:6546902 |
| Fuse S and Kamiya T | Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease. | 1994 | Circulation | pmid:7994842 |
| Fiorucci S et al. | NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. | 2002 | Circulation | pmid:12473561 |
| Rouvier J et al. | Aspirin resistance. | 2002 | Circulation | pmid:12473569 |
| De Caterina R et al. | Nitrates and endothelial prostacyclin production: studies in vitro. | 1985 | Circulation | pmid:3917245 |
| Théroux P et al. | Fibrinopeptide A and platelet factor levels in unstable angina pectoris. | 1987 | Circulation | pmid:2947740 |
| Tada M et al. | Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris. | 1981 | Circulation | pmid:7296786 |
| Davies GC et al. | Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. | 1980 | Circulation | pmid:6965618 |
| RÃ¥ngemark C et al. | Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. | 1992 | Circulation | pmid:1423963 |
| Hennekens CH et al. | Terms and conditions: semantic complexity and aspirin resistance. | 2004 | Circulation | pmid:15381661 |
| Adatia I et al. | Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. | 1993 | Circulation | pmid:8222105 |
| Kyrle PA et al. | Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. | 1987 | Circulation | pmid:3552295 |
| Sobel M et al. | Circulating platelet products in unstable angina pectoris. | 1981 | Circulation | pmid:6450001 |
| Frelinger AL et al. | Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. | 2006 | Circulation | pmid:16785341 |
| Belton O et al. | Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. | 2000 | Circulation | pmid:10952950 |
| de Boer AC et al. | Platelet release and thromboxane synthesis in symptomatic coronary artery disease. | 1982 | Circulation | pmid:6212161 |
| Mehta J and Mehta P | Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease. | 1982 | Circulation | pmid:6216027 |
| Callahan KS et al. | Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. | 1985 | Circulation | pmid:2986877 |
| Fischer S et al. | The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man. | 1983 | Circulation | pmid:6352080 |
| Apprill P et al. | Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. | 1985 | Circulation | pmid:2988822 |
| Gurbel PA et al. | Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. | 2007 | Circulation | pmid:17562955 |
| Reilly M et al. | Modulation of oxidant stress in vivo in chronic cigarette smokers. | 1996 | Circulation | pmid:8964113 |
| Davì G et al. | Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. | 2003 | Circulation | pmid:12810609 |
| Yui Y et al. | Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. | 1984 | Circulation | pmid:6434196 |
| Patrignani P et al. | Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. | 2000 | Circulation | pmid:10920066 |
| Patrono C et al. | Clinical pharmacology of platelet cyclooxygenase inhibition. | 1985 | Circulation | pmid:3933848 |
| Davì G et al. | Oxidative stress and platelet activation in homozygous homocystinuria. | 2001 | Circulation | pmid:11535567 |
| Maree AO and Fitzgerald DJ | Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. | 2007 | Circulation | pmid:17452618 |
| Faraday N et al. | Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. | 2007 | Circulation | pmid:17470694 |
| Curl GR et al. | Beneficial effect of aspirin in maintaining the patency of small-caliber prosthetic grafts after thrombolysis with urokinase or tissue-type plasminogen activator. | 1986 | Circulation | pmid:3091289 |
| Montalescot G et al. | Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep. | 1990 | Circulation | pmid:2171807 |
| Capone ML et al. | Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. | 2004 | Circulation | pmid:15037526 |
| Neri Serneri GG et al. | Enhanced peripheral vasoconstrictor response and increased thromboxane A2 synthesis after the cold pressor test in patients with angina at rest. | 1986 | Circulation | pmid:3948351 |
| Lewy RI et al. | Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. | 1980 | Circulation | pmid:7371128 |
| Burleigh ME et al. | Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. | 2002 | Circulation | pmid:11956125 |
| Friedman M et al. | Parameters of pulmonary injury after total or partial cardiopulmonary bypass. | 1994 | Circulation | pmid:7955263 |
| Livingston ER et al. | Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. | 1996 | Circulation | pmid:8901751 |
| Vejar M et al. | Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina. | 1990 | Circulation | pmid:2403867 |
| Eikelboom JW et al. | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. | 2002 | Circulation | pmid:11940542 |
| Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT). | 1994 | Circulation | pmid:8313547 | |
| Nowak J et al. | Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. | 1987 | Circulation | pmid:3297389 |
| Grande P et al. | Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. | 1990 | Circulation | pmid:2136815 |
| Gershlick AH | Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically? | 1990 | Circulation | pmid:2136816 |
| Rossini M et al. | Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. | 1990 | Circulation | pmid:2136819 |
| Eikelboom JW et al. | Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. | 2008 | Circulation | pmid:18838564 |
| Gerrard JM et al. | In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin. | 1989 | Circulation | pmid:2910545 |
| Larsson PT et al. | Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. | 1994 | Circulation | pmid:8181117 |
| Montalescot G et al. | Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris. | 1991 | Circulation | pmid:1934381 |
| Yokoyama C et al. | Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction. | 2002 | Circulation | pmid:12403673 |
| Cattaneo M | Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". | 2009 | Circulation | pmid:19546394 |
| Davì G et al. | Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. | 1997 | Circulation | pmid:9236419 |
| Oviedo PJ et al. | Progestogens reduce thromboxane production by cultured human endothelial cells. | 2011 | Climacteric | pmid:20443717 |
| Tanabe K et al. | Erythrocyte magnesium and prostaglandin dynamics in chronic sleep deprivation. | 1997 | Clin Cardiol | pmid:9068914 |
| Lewy RI et al. | Comparison of plasma concentrations of thromboxane B2 in Prinzmetal's variant angina and classical angina pectoris. | 1979 | Clin Cardiol | pmid:544110 |
| Vicari AM et al. | Effects of acute smoking on the hemostatic system in humans. | 1988 | Clin Cardiol | pmid:2971495 |
| Salvetti A et al. | Indomethacin reduces the antihypertensive action of enalapril. | 1987 | Clin Exp Hypertens A | pmid:3038418 |
| Omata K et al. | Role of endogenous angiotensin II and prostaglandins in the antihypertensive mechanism of angiotensin converting enzyme inhibitor in hypertension. | 1987 | Clin Exp Hypertens A | pmid:3038419 |
| Mück AO et al. | The effect of 17 beta-estradiol and endothelin 1 on prostacyclin and thromboxane production in human endothelial cell cultures. | 1993 | Clin Exp Obstet Gynecol | pmid:8281701 |
| Gomi T et al. | Protective effect of thromboxane synthetase inhibitor on hypertensive renal damage in Dahl salt-sensitive rats. | 1995 | Clin Exp Pharmacol Physiol Suppl | pmid:9072433 |
| Kim RB et al. | Effects of indomethacin on furosemide induced renal prostaglandin synthesis and action in man. | 1986 | Clin Invest Med | pmid:3530574 |
| Gerrard JM et al. | A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time. | 1989 | Clin Invest Med | pmid:2787219 |
| Smallbone BW et al. | Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep. | 1986 | Clin Invest Med | pmid:3757320 |
| Walshaw PE et al. | Diuretic and non-diuretic actions of furosemide: effects of probenecid. | 1992 | Clin Invest Med | pmid:1572111 |
| Waslen TA et al. | Sulindac does not spare renal prostaglandins. | 1989 | Clin Invest Med | pmid:2650941 |
| Goerig M et al. | A new role for nicotine: selective inhibition of thromboxane formation by direct interaction with thromboxane synthase in human promyelocytic leukaemia cells differentiating into macrophages. | 1992 Mar-Apr | Clin Investig | pmid:1521038 |
| Broekema FI et al. | In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin. | 2013 | Clin Oral Investig | pmid:22855267 |
| Awni WM et al. | The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers. | 1995 | Clin Pharmacokinet | pmid:8620667 |
| Cerletti C et al. | Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. | 2003 | Clin Pharmacokinet | pmid:12959636 |
| Neiman J et al. | Increased urinary excretion of a major thromboxane metabolite in early alcohol withdrawal. | 1994 | Clin Physiol | pmid:7955938 |
| Wennmalm A et al. | Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. | 1988 | Clin Physiol | pmid:3402185 |
| Hüttemeier P et al. | Effects of a thromboxane antagonist (BM 13.177) during endotoxin-induced pulmonary vasoconstriction in sheep. | 1986 | Clin Physiol | pmid:3536270 |
| Nowak J et al. | Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. | 1996 | Clin Physiol | pmid:8842572 |
| Sagripanti A et al. | [The use of picotamide in nephropathy with mesangial IgA deposits. The effect on thromboxane generation]. | 1993 | Clin Ter | pmid:8472511 |
| Angiolillo DJ et al. | Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial. | 2011 | Clin Ther | pmid:22078153 |
| Brunner D et al. | Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus. | 1984 | Clin Ther | pmid:6206948 |
| Graff J et al. | Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. | 2007 | Clin Ther | pmid:17577465 |
| Tohjima T et al. | In vitro effects of trapidil on fatty acid and prostaglandin metabolism in platelets. | 1994 May-Jun | Clin Ther | pmid:7923307 |
| Cryer B et al. | Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. | 2005 | Clin Ther | pmid:15811481 |
| Arakawa M et al. | Effects of ulinastatin, an antiprotease, on alloxan-induced lung injury in dogs. | 1992 May-Jun | Clin Ther | pmid:1638581 |
| Waysbort J et al. | Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus. | 1988 | Clin Ther | pmid:2978874 |
| Dołegowska B et al. | Dynamics of thromboxane level changes during early phase of allograft reperfusion. | 2009 Sep-Oct | Clin Transplant | pmid:19298388 |
| Fuller RW and MacDermot J | Stimulation of IgE sensitized human alveolar macrophages by anti-IgE is unaffected by sodium cromoglycate. | 1986 | Clin. Allergy | pmid:3098449 |
| Feldman M et al. | A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women. | 2001 | Clin. Appl. Thromb. Hemost. | pmid:11190906 |
| Kotamäki M | Smoking induced differences in autonomic responses in military pilot candidates. | 1995 | Clin. Auton. Res. | pmid:7780288 |
| Smith CC et al. | The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man. | 1993 | Clin. Auton. Res. | pmid:8477181 |
| Bing RJ et al. | Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. | 2001 | Clin. Cancer Res. | pmid:11705852 |
| McCann DS et al. | Radioimmunoassay for plasma thromboxane B2. | 1981 | Clin. Chem. | pmid:7273401 |
| Ivandic BT et al. | Determination of aspirin responsiveness by use of whole blood platelet aggregometry. | 2007 | Clin. Chem. | pmid:17332149 |
| Djurup R et al. | Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. | 1993 | Clin. Chem. | pmid:8252718 |
| Karon BS et al. | Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. | 2008 | Clin. Chem. | pmid:18420732 |
| Gonzalez-Revalderia J et al. | Usefulness of thromboxane B2 in diagnosis of renal transplant rejection. | 1991 | Clin. Chem. | pmid:1764806 |
| Lowe FJ et al. | Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. | 2009 | Clin. Chem. Lab. Med. | pmid:19676143 |
| Gonçalves LH et al. | Urinary 11-dehydro thromboxane B₂ levels in type 2 diabetic patients before and during aspirin intake. | 2011 | Clin. Chim. Acta | pmid:21510926 |
| Lee TK et al. | Effect of low dose acetylsalicylic acid upon plasma thromboxane B2 levels and platelet aggregation in ischemic stroke patients. | 1989 | Clin. Chim. Acta | pmid:2612002 |